SCHEMBL21240860

SCHEMBL21240860

CC(C)n1cnc2c(NCCc3ccncc3)nc(-c3cccnc3)nc21.CC(C)n1cnc2c(NCCc3cnc4[nH]ccc4c3)nc(-c3cccnc3)nc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AHR P35869 1/20 0.45
▸ CCNK O75909 6/20 0.43
▸ CDK12 Q9NYV4 6/20 0.43
▸ CDK2 P24941 9/20 0.42
▸ CDK9 P50750 4/20 0.42
▸ CCNE1 P24864 6/20 0.42
▸ CCNE2 O96020 3/20 0.42
▸ CCNA2 P20248 3/20 0.42
▸ CCNA1 P78396 3/20 0.42
▸ CDK1 P06493 7/20 0.42
▸ CCNB1 P14635 5/20 0.42
▸ CDK4 P11802 4/20 0.42
▸ MAPK1 P28482 4/20 0.42
▸ CDK7 P50613 4/20 0.42
▸ CDK5 Q00535 4/20 0.42
▸ CCNH P51946 3/20 0.42
▸ CCND1 P24385 2/20 0.42
▸ CCNT1 O60563 2/20 0.42
▸ MNAT1 P51948 1/20 0.42
▸ CDK6 Q00534 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2357914 0.97 AHR (0.46) AHRCCNKCDK12CDK2CDK9
SCHEMBL2318356 0.89 AHR (0.51) AHRCCNKCDK12CDK2CDK9
SCHEMBL15684650 0.86 CCNK (0.47) AHRCCNKCDK12CDK2CDK9
SCHEMBL21016907 0.85 AHR (0.44) AHRCCNKCDK12CDK2CDK9
SCHEMBL2317564 0.82 AHR (0.62) AHRCDK2CDK9CCNE1CCNE2
SCHEMBL20895840 0.82 AHR (0.49) AHRCDK2CDK9CCNE1CCNE2
SCHEMBL15010781 0.80 CCNK (0.38) AHRCCNKCDK12CDK2CDK9
SCHEMBL13282111 0.80 AHR (0.46) AHRCCNKCDK12CDK2CDK9
SCHEMBL2358541 0.80 CCNK (0.52) AHRCCNKCDK12CDK2CDK9
SCHEMBL20895820 0.80 CDK2 (0.51) AHRCCNKCDK12CDK2CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3524604-A1 EXPANDED HEMATOPOIETIC STEM CELLS FROM CORD BLOOD AND THEIR THERAPEUTIC USE Novartis AG (CH) 2019-08-14 — — EP disclosed
Send feedback